{
    "2019-09-10": [
        [
            {
                "time": "",
                "original_text": "孙飘扬、陈启宇、吕明方往一个城墙口冲锋：中国药企进军世界前列的准备、挑战、时间",
                "features": {
                    "keywords": [
                        "孙飘扬",
                        "陈启宇",
                        "吕明方",
                        "中国药企",
                        "世界前列",
                        "挑战"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药(02607.HK)控股股东上实集团增持19.35万股H股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "上实集团",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华鑫证券：医药生物板块业绩增长稳健 配置价值显著",
                "features": {
                    "keywords": [
                        "华鑫证券",
                        "医药生物",
                        "业绩增长",
                        "配置价值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "营收百亿药企大比拼：恒瑞、复星、上药",
                "features": {
                    "keywords": [
                        "营收百亿",
                        "恒瑞",
                        "复星",
                        "上药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "央地重组，*ST沈机将重构机床格局？",
                "features": {
                    "keywords": [
                        "央地重组",
                        "*ST沈机",
                        "机床格局"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "工业制造"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：工业保持快速增长，商业龙头效应凸显",
                "features": {
                    "keywords": [
                        "上海医药",
                        "工业增长",
                        "商业龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}